More analysis of Acthar in infantile spasms required
This article was originally published in Scrip
Executive Summary
The US FDA has requested that Questcor provide additional analysis of data from a clinical trial which was filed as part of its supplementalNDA for Acthar gel (repository corticotrophin injection) in infantile spasms.